GL1X · GenesisL1 explorer

Research workbench

The crystal structure of protease SAPP1P from candida parapsilosis in complex with the HIV protease inhibitor ritonavir

Analyse The crystal structure of protease SAPP1P from candida parapsilosis in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3TNE
Type
protein
Length
678 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Secreted aspartic protease
EC
3.4.23.24
UniProt
B8YPM3
Ligands
RIT
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 9% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BSecreted aspartic protease (EC 3.4.23.24)protein3399% helix, 45% strandB8YPM3

Ligands and binding sites

  • RIT · Ritonavir · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18200.700.7678RIT
28260.700.7666RIT

Interfaces

1 interface between chains.

  • A–B · 1355 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 3TNE · The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.